John Y. Caloz
2018
In 2018, John Y. Caloz earned a total compensation of $500K as Chief Financial Officer and Treasurer at CytRx, a 13% decrease compared to previous year.
Compensation breakdown
| Bonus | $100,000 |
|---|---|
| Salary | $400,000 |
| Total | $500,000 |
Caloz received $400K in salary, accounting for 80% of the total pay in 2018.
Caloz also received $100K in bonus.
Rankings
In 2018, John Y. Caloz's compensation ranked 11,878th out of 14,244 executives tracked by ExecPay. In other words, Caloz earned more than 16.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,878 out of 14,244 | 17th |
Division Manufacturing | 4,812 out of 5,765 | 17th |
Major group Chemicals And Allied Products | 1,823 out of 2,128 | 14th |
Industry group Drugs | 1,556 out of 1,817 | 14th |
Industry Biological Products, Except Diagnostic Substances | 301 out of 339 | 11th |
Source: SEC filing on June 26, 2019.
Caloz's colleagues
We found two more compensation records of executives who worked with John Y. Caloz at CytRx in 2018.
News
CytRx CEO Stephen Snowdy's 2023 pay slips 3% to $545K
August 20, 2024
CytRx CEO Stephen Snowdy receives $563K in 2022
July 28, 2023
CytRx CEO Steven Kriegsman's 2021 pay jumps 592% to $7M
June 16, 2022
CytRx CEO Steven Kriegsman's 2020 pay falls 41% to $1M
June 14, 2021
CytRx CEO Steven Kriegsman's 2019 pay jumps 68% to $1.7M
June 12, 2020
CytRx CEO Steven Kriegsman's 2018 pay falls 48% to $1M
June 26, 2019